2017


To access this material please log in or register

Register Authorize
2017/№S2

Clinical and demographic characteristics of an outpatient Russian population with chronic heart failure at the time of enrollment in the QUALIFY registry for evaluating consistency with clinical guidelines on drug therapy

Tereshchenko S. N., Zhirov I. V., Petrukhina A. A.
Russian Cardiology Science and Production Center, 3rd Cherepkovskaya 15a, Moscow 121552, Russia

Keywords: chronic heart failure, guidelines, pharmacological treatment, recommendations adherence

DOI: 10.18087/cardio.2363

Background. Chronic heart failure is the most common condition in patients with cardiovascular diseases. Therefore, evaluating consistency of doctor’s recommendations with guidelines on drug therapy is a relevant issue. Aim. To evaluate consistency of doctor’s recommendations with guidelines on drug therapy for CHF. Materials and methods. The study presents enrollment visit data for the Russian part of the international prospective registry, QUALIFY. The study included 404 outpatient patients with CHF between February, 2013 through June, 2014. Consistency with guidelines for drug therapy was evaluated for 5 drug classes, including ACE inhibitors (ACEI), β-blockers (BB), angiotensin receptor antagonists (ARA), mineralocorticoid receptor antagonists (MRA), and ivabradine. Results. On the whole, the consistency was good in 64.9% of cases, moderate in 27.7% of cases, and poor in 7.4% of cases. Proportions of patients who received a target dose of a medicine and a dose ≥50% of the target dose were low, 21.5% and 62.3% for ACEI; 15% and 50.8% for BB; 20.3% and 39.8% for ARA; and 23.4% and 78.7% for ivabradine, respectively. These values, except for BB, were lower for patients with late hospitalization (hospitalization ≥6 months vs. <6 months). Conclusion. Data of the registry showed that consistency of doctors’ recommendations with guidelines on drug prescription was generally satisfactory. However, doses of medicines recommended for the treatment of CHF were lower than optimum. It is essential to develop a tactic for implementing guidelines on the treatment of CHF in clinical practice.
  1. Tavazzi L, Senni M, Metra M, Gorini M, Cacciatore G, Chinaglia A et al. Multicenter Prospective Observational Study on Acute and Chronic Heart Failure: One-Year Follow-up Results of IN-HF (Italian Network on Heart Failure) Outcome Registry. Circulation: Heart Failure. 2013;6(3):473–81. DOI:10.1161/CIRCHEARTFAILURE.112.000161.
  2. Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J et al. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail. 2013;15(7):808–17. DOI:10.1093/eurjhf/hft050.
  3. Jhund PS, MacIntyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A et al. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People. Circulation. 2009;119(4):515–23. DOI:10.1161/CIRCULATIONAHA.108.812172.
  4. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22(4 Suppl A):6A–13A.
  5. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102(10):1126–31.
  6. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A et al. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J. 2001;22(15):1318–27. DOI:10.1053/euhj.2000.2533.
  7. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, Poole-Wilson PA et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83(5):505–10.
  8. Authors/Task Force Members, McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaborati. European Journal of Heart Failure. 2012;14(8):803–69. DOI:10.1093/eurjhf/hfs105.
  9. 2009 writing group to review new evidence and update the 2005 guideline for the management of patients with chronic heart failure writing on behalf of the 2005 heart failure writing committee, Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977–2016. DOI:10.1161/CIRCULATIONAHA.109.192064.
  10. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A et al. The EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J. 2003;24(5):464–74.
  11. de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M et al. Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. European Journal of Heart Failure. 2007;9(12):1205–11. DOI:10.1016/j.ejheart.2007.09.008.
  12. Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry. European Journal of Heart Failure. 2013;15(10):1173–84. DOI:10.1093/eurjhf/hft134.
  13. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. The Lancet. 2010;376(9744):875–85. DOI:10.1016/S0140-6736(10)61198-1.
  14. Authors/Task Force Members Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJV, Ponikowski P et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal. 2008;29(19):2388–442. DOI:10.1093/eurheartj/ehn309.
  15. Komajda M, Anker SD, Cowie MR, Filippatos GS, Mengelle B, Ponikowski P et al. Physicians’ adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey: Adherence to heart failure guidelines. European Journal of Heart Failure. 2016;18(5):514–22. DOI:10.1002/ejhf.510.
  16. Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C et al. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: The FUTURE survey. Archives of Cardiovascular Diseases. 2012;105(6–7):355–65. DOI:10.1016/j.acvd.2012.04.003.
  17. Poelzl G, Altenberger J, Pacher R, Ebner C h., Wieser M, Winter A et al. Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failure. International Journal of Cardiology. 2014;175(1):83–9. DOI:10.1016/j.ijcard.2014.04.255.
  18. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M et al. Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF. Circulation: Heart Failure. 2008;1(2):98–106. DOI:10.1161/CIRCHEARTFAILURE.108.772228.
  19. Арутюнов А. Г., Драгунов Д. О., Арутюнов Г. П., Рылова А. К., Пашкевич Д. Д., Витер К. В. и др. Первое открытое исследование синдрома острой декомпенсации сердечной недостаточности и сопутствующих заболеваний в Российской Федерации. Независимый регистр ОРАКУЛ–РФ. Кардиология. 2015;55(5):12–21 [Arutyunov A. G., Dragunov D. O., Arutyunov G. P., Ry`lova A. K., Pashkevich D. D., Viter K. V. i dr. Pervoe otkry`toe issledovanie sindroma ostroj dekompensaczii serdechnoj nedostatochnosti i soputstvuyushhix zabolevanij v Rossijskoj Federaczii. Nezavisimy`j registr ORAKUL–RF. Kardiologiya. 2015;55(5):12–21].
  20. Арутюнов А. Г., Рылова А. К., Арутюнов Г. П. Регистр госпитализированных пациентов с декомпенсацией кровообращения (Павловский регистр). Сообщение 1. Современная клиническая характеристика пациента с декомпенсацией кровообращения. Клинические фенотипы пациентов. Журнал Сердечная Недостаточность. 2014;15(1):23–32 [Arutyunov A. G., Ry`lova A. K., Arutyunov G. P. Registr gospitalizirovanny`x paczientov s dekompensacziej krovoobrashheniya (Pavlovskij registr). Soobshhenie 1. Sovremennaya klinicheskaya xarakteristika paczienta s dekompensacziej krovoobrashheniya. Klinicheskie fenotipy` paczientov. Zhurnal Serdechnaya Nedostatochnost`. 2014;15(1):23–32].
  21. Арутюнов А. Г., Рылова А. К., Арутюнов Г. П. Регистр госпитализированных пациентов с декомпенсацией кровообращения (регистр Павловской больницы). Сообщение 2. Клиническое значение и прогностическая роль некоторых параметров, определяемых при физикальном и инструментальном обследовании пациентов с декомпенсацией кровообращения. Журнал Сердечная Недостаточность. 2014;15(2):67–75. DOI:10.18087/rhfj.2014.2.1934 [Arutyunov A. G., Ry`lova A. K., Arutyunov G. P. Registr gospitalizirovanny`x paczientov s dekompensacziej krovoobrashheniya (registr Pavlovskoj bol`niczy`). Soobshhenie 2. Klinicheskoe znachenie i prognosticheskaya rol` nekotory`x parametrov, opredelyaemy`x pri fizikal`nom i instrumental`nom obsledovanii paczientov s dekompensacziej krovoobrashheniya. Zhurnal Serdechnaya Nedostatochnost`. 2014;15(2):67–75. DOI:10.18087/rhfj.2014.2.1934].
  22. Арутюнов А. Г., Драгунов Д. О., Арутюнов Г. П., Соколова А. В. Влияние величины дозы основных препаратов на риск повторных госпитализаций пациентов с хронической сердечной недостаточностью. Терапевтический архив. 2016;88(1):29–34 [Arutyunov A. G., Dragunov D. O., Arutyunov G. P., Sokolova A. V. Vliyanie velichiny` dozy` osnovny`x preparatov na risk povtorny`x gospitalizaczij paczientov s xronicheskoj serdechnoj nedostatochnost`yu. Terapevticheskij arxiv. 2016;88(1):29–34].
Tereshchenko S. N., Zhirov I. V., Petrukhina A. A. Clinical and demographic characteristics of an outpatient Russian population with chronic heart failure at the time of enrollment in the QUALIFY registry for evaluating consistency with clinical guidelines on drug therapy. Kardiologiia. 2017;57(S2):324–330

To access this material please log in or register

Register Authorize
Ru En